» Articles » PMID: 24258072

Incidence of Sudden Cardiac Death After Ventricular Fibrillation Complicating Acute Myocardial Infarction: a 5-year Cause-of-death Analysis of the FAST-MI 2005 Registry

Abstract

Aims: Limited data are available on long-term prognosis or causes-of-death analysis among survivors of acute myocardial infarction (MI) according to whether or not they developed ventricular fibrillation (VF) during the acute stage of MI.

Methods And Results: Among 3670 MI patients hospitalized in France in 2005 and enrolled in this prospective follow-up cohort study, we assessed in-hospital mortality and 5-year cause of death among those who survived to hospital discharge, according to whether they developed VF (116 cases) or not, during the acute stage. 94.5% of patients had complete follow-up at 5 years. In-hospital mortality was significantly higher among VF patients (adjusted OR 7.38, 95% CI 4.27-12.75, P < 0.001). Among 3463 survivors at hospital discharge, 1024 died during a mean follow-up of 52 ± 2 months. The overall survival rate at 5 years was 74.4% (95% CI 72.8-76.0). In Cox multivariate analysis, occurrence of VF during the acute phase of MI was not associated with an increased mortality at 5 years (HR 0.78, 95% CI 0.38-1.58, P = 0.21). The distribution of causes of death at 5 years did not statistically differ according to the presence or absence of VF, especially for sudden cardiac death (13.1% in VF group vs.12.9% in non-VF group), despite a very low rate of implantation of cardioverter defibrillator in both groups (Overall rate 1.2%).

Conclusion: Patients developing VF in the setting of acute MI are at higher risk of in-hospital mortality. However, VF is not associated with a higher long-term all-cause or sudden cardiac death mortality.

Citing Articles

A combination of left ventricular outflow tract velocity time integral and lung ultrasound to predict mortality in ST elevation myocardial infarction.

Machado G, Telo G, Araujo G, da Rosa Barbato J, Amon A, Martins A Intern Emerg Med. 2024; 19(8):2167-2176.

PMID: 39044051 DOI: 10.1007/s11739-024-03719-z.


Ventricular arrhythmias during ST-segment elevation myocardial infarction and arrhythmic complications during recurrent ischaemic events.

Demidova M, Holmqvist F, Erlinge D, Platonov P Eur Heart J. 2023; 45(5):393-395.

PMID: 37935589 PMC: 10834155. DOI: 10.1093/eurheartj/ehad740.


Prognostic significance of the Holter-derived T-wave variability in patients with ventricular tachyarrhythmias complicating acute coronary syndrome-TWIST study.

Makino T, Ichikawa T, Amino M, Nakamura M, Koshikawa M, Motoike Y Ann Noninvasive Electrocardiol. 2023; 28(6):e13069.

PMID: 37740449 PMC: 10646380. DOI: 10.1111/anec.13069.


Arrhythmias After Acute Myocardial Infarction.

Frampton J, Ortengren A, Zeitler E Yale J Biol Med. 2023; 96(1):83-94.

PMID: 37009192 PMC: 10052595. DOI: 10.59249/LSWK8578.


Prognostic value of early sustained ventricular arrhythmias in ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: A substudy of VALIDATE-SWEDEHEART trial.

Demidova M, Rylance R, Koul S, Dworeck C, James S, Aasa M Heart Rhythm O2. 2023; 4(3):200-206.

PMID: 36993916 PMC: 10041082. DOI: 10.1016/j.hroo.2022.12.008.